NovaGo Therapeutics

NovaGo Therapeutics was founded in 2015, is headquartered in Schlieren, Switzerland, lists 1–10 employees, and has $41.0M in recorded funding across 2 rounds.

Headquarters
Schlieren, ZH
Employees
1–10
Founded
2015
Total Funding
$41.0M
Last Round
$30.0M Series BSep 2026
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

NovaGo Therapeutics is a Swiss clinical-stage biotech company founded in 2015 in Zurich-Schlieren as a spin-off from the University of Zurich. NovaGo's science is built on the discovery that the protein Nogo-A actively inhibits nerve-fiber growth and regeneration in the brain and spinal cord, and its antibody therapeutics aim to temporarily block Nogo-A to re-open a window for repair after spinal cord injury and ischemic stroke. Its lead candidate, NG004, is in a Phase 1b clinical trial, and NovaGo closed a USD 30 million Series B financing round led by Neurimmune and Pureos Bioventures.

Summary

NovaGo Therapeutics is a Biotech company based in Schlieren, Switzerland, founded in 2015. It lists 1–10 employees. It has raised $41.0M in total across 2 rounds, most recently a $30.0M Series B round in Sep 2026. Investors include BB Pureos and Kinled Holding.

Funding History

Series BSeries BSep 2026
$30.0M

Sign up to see all 2 events

Funding: Series A through Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
ParexelAcquired

One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...

Raleigh, United States10001+Biotech
Private EquityTotal funding$5.0BJun 2017
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

NovaGo Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/novago-therapeutics"><img src="https://indexed.vc/api/badge/company/novago-therapeutics" alt="NovaGo Therapeutics on Indexed.vc" width="260" height="76" /></a>